### [3D Printing in China Hits Inflection Point – Aerospace, Medical & IPO Pipeline Fuel New Growth Cycle](https://linkinchina.com/en/article/237)

**Published:** 2026-02-04T13:46:33

**Author:** arvin

**Excerpt:** You’re watching China’s 3D printing sector surge in aerospace and medical tech, but the real story isn’t just growth—it’s *how fast* these companies are shifting from R&D labs to mass production. We analyzed the latest earnings: one firm saw net profit double, another tripled adjusted profits, all while quietly supplying reusable rockets and FDA-cleared dental implants. The surprise? It’s not government funding driving this—it’s commercial demand from unexpected industries. And with multiple firms lining up for IPOs, there’s a hidden risk few investors see coming. What if the biggest winner isn’t a printer maker at all, but a supplier hiding in plain sight?

![](https://server.linkinchina.com/wp-content/plugins/xhtheme-ai-toolbox/assets/images/aurora-bg.svg)

摘要生成中

AI生成，仅供参考

**Title: 3D Printing in China Hits Inflection Point – Aerospace, Medical & IPO Pipeline Fuel New Growth Cycle**  
**Author: Arvin**  
**Date: February 4, 2026**

* * *

The Chinese 3D printing (additive manufacturing) industry has kicked off 2026 with unmistakable momentum. Fueled by **breakthrough earnings**, **strategic M&A**, **cross-sector adoption**, and a **robust IPO pipeline**, the sector is transitioning from niche innovation to scalable commercialization—particularly in aerospace, consumer electronics, and medical applications.

For international investors focused on A- and H-share opportunities, this marks a pivotal moment to reassess exposure to China’s advanced manufacturing ecosystem. Below, we unpack the key drivers, leading players, and strategic implications based on recent disclosures and market developments.

* * *

### Earnings Surge: Proof of Commercial Traction

Several listed companies have reported **exceptional 2025 full-year results**, validating 3D printing’s role as a profit engine—not just an R&D expense.

-   **【铂力特–Xi’an Bright Laser Technologies–688333.SH–Industrial 3D Printing】**  
    The undisputed leader delivered a stunning performance:
    
    -   Revenue: **RMB 1.863 billion (+40.5% YoY)**
    -   Net profit: **RMB 209 million (+100.96%)**
    -   Adjusted net profit: **RMB 149 million (+313.89%)**
    
    Growth was driven by **civilian market expansion** and **aerospace mass production**. Notably, Platinum successfully supported **LandSpace’s Zhuque-3 reusable rocket** in its first large-scale vertical takeoff and landing test—marking a shift from prototyping to **batch manufacturing** for commercial space firms like **LandSpace**, **Orienspace**, and **iSpace**.
    
-   **【爱司凯–Amsky Technology–300521.SZ–3D Printing Equipment】**  
    While overall revenue remained flat (~RMB 1.85–2.05 billion), its **3D printing equipment segment surged +55% YoY**, offsetting declines in legacy CTP printing business. The company increased R&D and staffing costs by **RMB 90 million**, signaling aggressive investment in scaling.
-   **【统联精密–Tonglian Precision–688210.SH–Precision Components】**  
    Added **RMB 34 million** in 3D printing R&D expenses to support lightweight structural parts for next-gen consumer electronics and automotive clients.
-   **【鸿日达–Hongrida–301285.SZ–Connectors & Components】**  
    Expanded into **optical communications and 3D printing**, with related expenses rising “significantly” year-over-year.
-   **【爱迪特–Idea Dental–301580.SZ–Dental Materials & Devices】**  
    Explicitly stated that **3D printing will be a new growth engine**. Its **EZprint-P1 dental printer**—lauded for high-speed output—is now clinically validated across **implantology and orthodontics**, with commercial rollout accelerating.

* * *

### Strategic Expansion: M&A, JVs & Cross-Industry Entry

Beyond organic growth, companies are reshaping the competitive landscape through capital-driven moves:

-   **【华曙高科–Farsoon Technologies–688433.SH–Industrial 3D Printing】**  
    Announced a **RMB 100 million joint venture** (40% stake) focused on **3C, automotive, and precision consumer parts**—a clear push into high-volume civilian markets.
-   **【飞沃科技–Feiwo Tech–301232.SZ–Aerospace Fasteners】**  
    Acquired **60% of Xinshan Aerospace**, a specialist in **liquid rocket engine components** (nozzles, combustion chambers, valves). The target generated **RMB 10.81 million in commercial space revenue in 2025**—small but strategically vital.
-   **【哈森股份–Harson Co., Ltd.–603958.SH–Footwear Retail】**  
    In a striking pivot, this traditional shoe brand has built a full-stack **metal additive manufacturing platform**, covering **powder materials, 3D printers, and precision metal parts** for consumer electronics. This exemplifies the **“cross-industry convergence”** trend sweeping Chinese manufacturing.

* * *

### IPO Pipeline: The Next Wave of Public Exposure

A strong cohort of private 3D printing firms is advancing toward public listings—offering future liquidity and diversification for global investors:

-   **Hangzhou Eplus3D** → Applying for **SSE STAR Market (Sci-Tech Innovation Board)**
-   **Shenzhen Creality 3D** → Filed for **HKEX listing** (August 2025)
    -   Revenue: RMB 2.288 billion in 2024; RMB 708 million in Q1 2025
    -   Focus: **Consumer-grade desktop 3D printers** (global leader in volume)
-   **Shining 3D (Xianlin Tech)** → Submitted application to **Beijing Stock Exchange (BSE)**
-   Others in IPO counseling: **Yuding AM**, **Polymaker (Suzhou Jufu)**, **BMF (Chongqing MoFang)**

This pipeline ensures the sector will remain in the spotlight—and provides multiple entry points across **industrial, medical, and consumer segments**.

* * *

### Investment Implications for A/H Investors

China’s 3D printing sector is no longer speculative. It is now delivering:  
✅ **Profitability at scale** (Platinum)  
✅ **Vertical integration** (Harson, Feiwo)  
✅ **Cross-industry applicability** (dental, aerospace, consumer electronics)  
✅ **Policy alignment** with “new quality productive forces” and advanced manufacturing mandates

**Top strategic picks** for overseas investors:

-   **Core enablers**: 【铂力特–688333.SH】, 【华曙高科–688433.SH】
-   **Application leaders**: 【爱迪特–301580.SZ】 (medical), 【飞沃科技–301232.SZ】 (aerospace)
-   **Emerging integrators**: 【哈森股份–603958.SH】 (watch for execution risk)
-   **Future IPOs**: Monitor **Creality 3D (HK)** and **Eplus3D (STAR Market)**

> **Caution**: Valuations in the sector can be volatile. Focus on companies with **clear revenue visibility**, **customer concentration risk mitigation**, and **positive operating cash flow**—not just headline growth.

* * *

_Disclaimer: This blog is for informational purposes only and does not constitute financial advice or a recommendation to buy/sell securities. Always conduct independent due diligence before investing._

—  
**Arvin**  
Global Equity Analyst | Covering China’s Advanced Manufacturing & Tech Innovation  
_Delivering actionable insights for international investors in A/H shares._

**Tags:** A-Share Market, Hong Kong Stocks, Space

**Categories:** News and Editorials

---